cycloartane has been researched along with argentatin a in 2 studies
Studies (cycloartane) | Trials (cycloartane) | Recent Studies (post-2010) (cycloartane) | Studies (argentatin a) | Trials (argentatin a) | Recent Studies (post-2010) (argentatin a) |
---|---|---|---|---|---|
215 | 0 | 147 | 6 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Herrera, MP; Martinez-Mayorga, K; Martínez-Vázquez, A; Martínez-Vázquez, M; Parra-Delgado, H; Pérez-Flores, FJ; Romero, JC | 1 |
Couder-García, BDC; Jacobo-Herrera, NJ; Martínez-Vázquez, M; Rocha-Zavaleta, L; Tavarez-Santamaría, Z; Zentella-Dehesa, A | 1 |
2 other study(ies) available for cycloartane and argentatin a
Article | Year |
---|---|
Synthesis, anti-inflammatory activity and modeling studies of cycloartane-type terpenes derivatives isolated from Parthenium argentatum.
Topics: Animals; Anti-Inflammatory Agents; Asteraceae; Binding Sites; Cell Line; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edema; Macrophages; Male; Mice; Molecular Docking Simulation; Nitric Oxide; Protein Structure, Tertiary; Terpenes; Tetradecanoylphorbol Acetate; Triterpenes | 2014 |
A Higher Frequency Administration of the Nontoxic Cycloartane-Type Triterpene Argentatin A Improved Its Anti-Tumor Activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; beta-Galactosidase; Biomarkers; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Immunohistochemistry; Mice; Molecular Structure; Triterpenes; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |